When a person’s brain or heart stopped ticking, it means they declared dead. There is no more life. Or is there?
The latest research published in a paper proved that certain parts of the body remain active for some days. This study will change the way of our thinking about organ transplant. And our thinking our the time of death.
Research led by microbiologist Peter Noble, investigate the gene activity. The team investigating the gene activity in deceased mice and zebrafish.
This research prompted by previous research on the gene. Previous research identified genes in human cadavers. Genes were active even after death for more than 12 hours.
Researchers identified more than 1000 genes that were functioning even days after death. But it didn’t mean they were taking a bit longer to sputter out than the rest of the body.
In mice, researchers found 515 genes that were functioning for 24 hours after death. In the Zebra Fish, Researchers found 548 genes functioning for whole 4 days after death.
The team measured the fluctuating level of messengers RNA (mRNA). They measured mRNA for in Both Mice and Zebra Fish for 96 hours after their death.
MRNA is a kind of blueprint that tells our gene which protein need to produce. So if there are more mRNA in the cell, there are more genes active.
Researchers said that these ‘Postmortem’ genes weren’t any genes. They were the kind of genes that ramp up during emergencies.
Mitch Leslie said that some genes usually switch on to help form of an embryo. After that those genes never heard again except at death.
Noble told Leslie that development genes turned on after death.
Researchers said that all the genes were not beneficial. Certain genes promote cancer growth that sparked after death in these animals.
Building a new body or trying to reanimate a dead body is like the ‘zombie’ genes.
These genes are not strong enough to bring a dead mouse, zebrafish, or human back to life.
Understanding what these genes are doing. Why there is a massive impact on the patient living with transplants.
The study found that organ transplant recipients have a risk of developing cancer. These cancers are of 32 different types including liver and kidney cancer.
Doctors are struggling to mitigate this condition.
It means while transplantation is a life-saving therapy but it also increased the risk of cancer. And the doctor has no cure of mitigating this risk.
And we need to stress that they have not yet been peer-reviewed.
By publishing these paper online, Noble and his team are inviting researchers to get in early. They only need to critique their work before they submit this research to a journal.